Loss-of-function or underexpression of sortilin and its related family members has been shown to impact the pathogenic process in Alzheimer’s disease by increasing production of the Aβ peptide [73,74,75]. This evidence concerns the gene SORT1 and early-onset autosomal dominant Alzheimer disease.